Predictive Blood Biomarkers of Targeted Intervention for Chronic Mental Health Symptoms following Traumatic Brain Injury
Journal of Neurotrauma · 2025
DOI: 10.1089/neu.2024.0245 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neurotrauma, 2025. Verfasst von Shawn R Eagle und 11 weiteren Autor:innen. Beteiligte Einrichtung: University of Pittsburgh, Pittsburgh, Pennsylvania, USA. Hauptthemen laut MEDLINE: Brain Injuries, Traumatic, Biomarkers, Stress Disorders, Post-Traumatic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS.
Abstract (Originalsprache)
The purpose of this study was to assess the performance of predictive blood biomarkers for responsiveness to targeted treatments for chronic psychological issues years after traumatic brain injury (TBI). Targeted Evaluation Action and Monitoring of TBI was a prospective 6-month interventional trial of participants with chronic TBI sequelae (n = 95). Plasma biomarkers were analyzed pre-intervention: glial fibrillary acidic protein (GFAP), tau, hyperphosphorylated tau Thr231 (p-Tau), von Willebrand factor (vWF), brain lipid-binding protein (BLBP), ubiquitin C-terminal hydrolase-L1 (UCH-L1), vascular endothelial growth factor-a (VEGFa), and claudin-5 (CLDN5). Clinical outcomes included the Post-Traumatic Stress Disorder (PTSD) Checklist for DSM-5 (PCL-5) and Brief Symptom Inventory-18 (BSI-18). Regression models were built for change in PCL5/BSI-18. Biomarkers and covariates were included. Two models were built to identify responders (improved beyond the minimum clinically important difference). The model to predict change in PCL5 (R2=0.64; p < 0.001) included vWF (p = 0.032), BLBP (p = 0.001), tau (p = 0.002), VEGFa (p = 0.015), female sex (p = 0.06), and military status (p = 0.014). The model to predict change in BSI-18 (R2=0.42; p = 0.003) included vWF (p = 0.042), VEGFa (p = 0.09), BLBP (p = 0.01), CLDN5 (p < 0.001), female sex (p = 0.012), and military status (p = 0.004) as predictors. The model to differentiate participants who improved for PCL5 (R2=0.68; p < 0.001; AUC = 0.93) included vWF (p = 0.02), VEGFa (p = 0.008), and BLBP (p = 0.006). The model to differentiate participants who improved for BSI-18 (R2=0.25; p = 0.04; AUC = 0.75) included UCH-L1 (p = 0.03), GFAP (p = 0.06), and vWF (p = 0.03). Combinations of pre-intervention blood biomarkers were able to differentiate responders from nonresponders in both post-traumatic stress and overall psychological health domains.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
- Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
ORCID-Profile: Shawn R Eagle
Förderung
- NINDS NIH HHS
Zitieren
APA
Eagle, S. R., Svirsky, S. E., Puccio, A. M., Borrasso, A., Edelman, K., Beers, S., Agoston, D., Soose, R., Collins, M., Kontos, A., Schneider, W., & Okonkwo, D. O. (2025). Predictive Blood Biomarkers of Targeted Intervention for Chronic Mental Health Symptoms following Traumatic Brain Injury. Journal of Neurotrauma. https://doi.org/10.1089/neu.2024.0245
Vancouver
Eagle SR, Svirsky SE, Puccio AM, Borrasso A, Edelman K, Beers S, et al. Predictive Blood Biomarkers of Targeted Intervention for Chronic Mental Health Symptoms following Traumatic Brain Injury. Journal of Neurotrauma. 2025. doi:10.1089/neu.2024.0245
BibTeX
@article{Eagle2025,
author = {Eagle, Shawn R and Svirsky, Sarah E and Puccio, Ava M and Borrasso, Allison and Edelman, Kathryn and Beers, Sue and Agoston, Denes and Soose, Ryan and Collins, Michael and Kontos, Anthony and Schneider, Walter and Okonkwo, David O},
title = {Predictive Blood Biomarkers of Targeted Intervention for Chronic Mental Health Symptoms following Traumatic Brain Injury},
journal = {Journal of Neurotrauma},
year = {2025},
doi = {10.1089/neu.2024.0245}
}
EUVIMED